Conmed Corp (CNMD) 48.98 $CNMD
Strong And Under The Radar: Conmed (CNMD)
at The Street - Fri Feb 13, 8:46AM CST
Trade-Ideas LLC identified Conmed (CNMD) as a strong and under the radar candidate
CNMD: 48.98 (+1.80)
Uptrend Call Working As Conmed Stock Rises 14.8% (CNMD)
Comtex SmarTrend(R) - Mon Feb 09, 11:15AM CST
SmarTrend identified an Uptrend for Conmed (NASDAQ:CNMD) on October 27th, 2014 at $41.77. In approximately 4 months, Conmed has returned 14.82% as of today's recent price of $47.96.
CNMD: 48.98 (+1.80)
Update: CONMED Posted Unimpressive Q4 2014 And Full-Year Earnings - 2015 Should Be Better
Andy Batts - at Seeking Alpha - Thu Feb 05, 2:41PM CST
CNMD: 48.98 (+1.80)
CONMED Corporation to Present at the 2015 Leerink Global Healthcare Conference
Business Wire - Wed Feb 04, 3:06PM CST
CONMED Corporation (NASDAQ:CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, will present at the 2015 Leerink Global Healthcare Conference at 3:30 p.m. ET on Thursday, February 12, 2015 in New York, NY.
CNMD: 48.98 (+1.80)
CONMED Q4 Earnings Flat but Revenues Down, '15 View Cut - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 28, 11:20AM CST
CONMED Corporation (CNMD) posted adjusted earnings of 53 cents per share in the fourth quarter of 2014, which remained flat on a year-over-year basis.
HYH: 44.50 (+0.52), ABC: 100.34 (+0.51), BRLI: 34.63 (+0.06), CNMD: 48.98 (+1.80)
Conmed Q4 earnings up 11%
Seeking Alpha - at Seeking Alpha - Wed Jan 28, 9:51AM CST
CNMD: 48.98 (+1.80)
CONMED's (CNMD) CEO Curt Hartman on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Jan 27, 7:04PM CST
CNMD: 48.98 (+1.80)
Conmed posts 4Q profit
Automated Insights - Tue Jan 27, 4:15PM CST
UTICA, N.Y. (AP) _ Conmed Corp. (CNMD) on Tuesday reported fourth-quarter net income of $11.3 million.
CNMD: 48.98 (+1.80)
CONMED (CNMD) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Jan 27, 3:25PM CST
CNMD: 48.98 (+1.80)
CONMED misses by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Tue Jan 27, 3:08PM CST
CNMD: 48.98 (+1.80)
CONMED Corporation Announces Fourth Quarter and Full Year 2014 Financial Results
Marketwired - Tue Jan 27, 3:01PM CST
CONMED Corporation (NASDAQ: CNMD) today announced financial results for the fourth quarter and full year ended December 31, 2014.
CNMD: 48.98 (+1.80)
Notable earnings after Tuesday’s close
Seeking Alpha - at Seeking Alpha - Mon Jan 26, 4:35PM CST
VMW: 84.68 (+1.06), EA: 56.39 (+0.20), BXP: 141.08 (-1.58), AMCC: 5.21 (+0.06), ILMN: 198.54 (+1.81), ARAY: 8.00 (+0.24), MRCY: 17.42 (-0.17), JNPR: 23.84 (+0.19), YHOO: 44.42 (+0.50), T: 34.66 (+0.05), ACE: 113.05 (+0.09), CNMD: 48.98 (+1.80), FTK: 17.49 (+0.78), X: 26.36 (+1.12), AAPL: 127.08 (+0.62), SYK: 94.51 (+1.14), CLMS: 12.96 (-0.08), ETH: 27.00 (-0.24), OTEX: 61.19 (+0.99), AMGN: 153.48 (+0.30), CYT: 52.84 (+0.40), WDC: 107.61 (+0.42), POL: 40.05 (+0.20), TSS: 37.09 (+0.17), EZPW: 9.96 (-0.29), CNI: 70.04 (-0.39), DOX: 51.15 (+0.37), FSL: 37.53 (+2.83)
13.7% Return Seen to Date on SmarTrend Conmed Call (CNMD)
Comtex SmarTrend(R) - Fri Jan 23, 11:23AM CST
SmarTrend identified an Uptrend for Conmed (NASDAQ:CNMD) on October 27th, 2014 at $41.77. In approximately 3 months, Conmed has returned 13.69% as of today's recent price of $47.49.
CNMD: 48.98 (+1.80)
CONMED Announces Preliminary FY14 Results, Guides FY15 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 15, 10:50AM CST
CONMED Corporation (CNMD) estimates full-year 2014 revenues in the range of $739-$741 million while adjusted earnings are projected in the band of $1.90-$1.94 per share.
JNJ: 99.62 (+1.18), MDT: 75.26 (+0.33), CNMD: 48.98 (+1.80), SYK: 94.51 (+1.14)
Conmed reports preliminary results and provides outlook for 2015
Seeking Alpha - at Seeking Alpha - Wed Jan 14, 3:13PM CST
CNMD: 48.98 (+1.80)
CONMED Corporation Announces Preliminary 2014 Results Within Guidance Range and Issues 2015 Financial Guidance
Marketwired - Wed Jan 14, 6:00AM CST
CONMED Corporation (NASDAQ: CNMD) today announced preliminary 2014 results and issued financial guidance for 2015.
CNMD: 48.98 (+1.80)
Powered Surgical Instruments Market by Power Source, Product & by Application - Global Forecasts to 2019
M2 - Thu Jan 08, 6:39AM CST
Research and Markets (http://www.researchandmarkets.com/research/93kr85/powered_surgical) has announced the addition of the "Powered Surgical Instruments Market by Power Source, Product & by Application - Global Forecasts to 2019" report to their offering. The global powered surgical instruments market is estimated to be worth around $1.5 to 1.6 billion in 2014 and is expected to grow at a moderate CAGR during the forecast period of 2014 to 2019. In this report, the global powered surgical instruments market is segmented by power source, product, and application. The market, by power source, is segmented into electric-powered, battery-powered, and pneumatic instruments. By product, the market covers the handpieces; power source and control; and accessories segments. The handpieces market is further subdivided into drills, saws, reamers, staplers, vessel sealing devices, suction coagulators, laparoscopic instruments, shavers, wire/pin drivers, and others. Moreover, the power source and control is divided into electrosurgical units, batteries and chargers, electric consoles, and regulators. The accessories market is subdivided into surgical accessories, electrical accessories, and other accessories. Furthermore, on basis of application, the market is classified into orthopedic surgery, oral maxillofacial surgery, ENT surgery, neurosurgery, plastic and reconstructive surgery, and cardiothoracic surgery. By 2019, North America contributed the largest share to the global powered surgical instruments market, followed by Europe, Asia-Pacific, and RoW. Developed geographies like North America and Europe are likely to grow at a lower CAGR as compared to the Asia-Pacific market, which is expected to show the fastest growth during the forecast period, largely driven by the increased healthcare spending, advancing medical tourism industry, rising prevalence of chronic diseases, and increased accessibility to healthcare facilities. Major players in the powered surgical instruments market are B. Braun Melsungen AG (Germany), CONMED Corporation (U.S.), Covidien Plc (Ireland), Johnson & Johnson (U.S.), Medtronic, Inc. (U.S.), Stryker Corporation (U.S.), and Zimmer Holdings (U.S.), among others. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Global Powered Surgical Instruments Market, By Power Source 8 Global Powered Surgical Instruments Market, By Product 9 Global Powered Surgical Instruments Market, By Application 10 Powered Surgical Instruments Market, By Geography 11 Competitive Landscape 12 Company Profiles - B. Braun Melsungen AG - Brasseler Usa Inc. - Conmed Corporation - Covidien Public Limited Company - Johnson & Johnson - Medtronic, Inc. - Olympus Corporation - Smith and Nephew Plc - Stryker Corporation - Zimmer Holdings, Inc. For more information visit http://www.researchandmarkets.com/research/93...d_surgical
ZMH: 119.33 (+1.18), SNN: 35.82 (-0.28), JNJ: 99.62 (+1.18), MDT: 75.26 (+0.33), CNMD: 48.98 (+1.80), SYK: 94.51 (+1.14)
CONMED Corporation to Announce Fourth Quarter 2014 Financial Results on January 27, 2015
Marketwired - Thu Jan 08, 6:01AM CST
CONMED Corporation (NASDAQ: CNMD) announced today that it will report fourth quarter and full year 2014 financial results at 4:00 PM Eastern time on Tuesday, January 27, 2015, and will also hold a conference call at 4:30 PM Eastern Time that same day to discuss the results.
CNMD: 48.98 (+1.80)
CONMED Corporation to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Marketwired - Thu Dec 11, 6:00AM CST
CONMED Corporation (NASDAQ: CNMD), a medical technology company specializing in medical devices for orthopedic and general surgery, announced today that the Company will participate in the 33rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2015 at 8:30 AM Pacific Time. The event will be held in San Francisco at the Westin St. Francis Hotel.
JPM: 59.67 (+0.10), CNMD: 48.98 (+1.80)
Strong And Under The Radar: Conmed (CNMD)
at The Street - Fri Feb 13, 8:46AM CST
Trade-Ideas LLC identified Conmed (CNMD) as a strong and under the radar candidate
CNMD: 48.98 (+1.80)
Uptrend Call Working As Conmed Stock Rises 14.8% (CNMD)
Comtex SmarTrend(R) - Mon Feb 09, 11:15AM CST
SmarTrend identified an Uptrend for Conmed (NASDAQ:CNMD) on October 27th, 2014 at $41.77. In approximately 4 months, Conmed has returned 14.82% as of today's recent price of $47.96.
CNMD: 48.98 (+1.80)
Update: CONMED Posted Unimpressive Q4 2014 And Full-Year Earnings - 2015 Should Be Better
Andy Batts - at Seeking Alpha - Thu Feb 05, 2:41PM CST
CNMD: 48.98 (+1.80)
CONMED Corporation to Present at the 2015 Leerink Global Healthcare Conference
Business Wire - Wed Feb 04, 3:06PM CST
CONMED Corporation (NASDAQ:CNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, will present at the 2015 Leerink Global Healthcare Conference at 3:30 p.m. ET on Thursday, February 12, 2015 in New York, NY.
CNMD: 48.98 (+1.80)
CONMED Q4 Earnings Flat but Revenues Down, '15 View Cut - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 28, 11:20AM CST
CONMED Corporation (CNMD) posted adjusted earnings of 53 cents per share in the fourth quarter of 2014, which remained flat on a year-over-year basis.
HYH: 44.50 (+0.52), ABC: 100.34 (+0.51), BRLI: 34.63 (+0.06), CNMD: 48.98 (+1.80)
Conmed Q4 earnings up 11%
Seeking Alpha - at Seeking Alpha - Wed Jan 28, 9:51AM CST
CNMD: 48.98 (+1.80)
CONMED's (CNMD) CEO Curt Hartman on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Jan 27, 7:04PM CST
CNMD: 48.98 (+1.80)
Conmed posts 4Q profit
Automated Insights - Tue Jan 27, 4:15PM CST
UTICA, N.Y. (AP) _ Conmed Corp. (CNMD) on Tuesday reported fourth-quarter net income of $11.3 million.
CNMD: 48.98 (+1.80)
CONMED (CNMD) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Jan 27, 3:25PM CST
CNMD: 48.98 (+1.80)
CONMED misses by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Tue Jan 27, 3:08PM CST
CNMD: 48.98 (+1.80)
CONMED Corporation Announces Fourth Quarter and Full Year 2014 Financial Results
Marketwired - Tue Jan 27, 3:01PM CST
CONMED Corporation (NASDAQ: CNMD) today announced financial results for the fourth quarter and full year ended December 31, 2014.
CNMD: 48.98 (+1.80)
Notable earnings after Tuesday’s close
Seeking Alpha - at Seeking Alpha - Mon Jan 26, 4:35PM CST
VMW: 84.68 (+1.06), EA: 56.39 (+0.20), BXP: 141.08 (-1.58), AMCC: 5.21 (+0.06), ILMN: 198.54 (+1.81), ARAY: 8.00 (+0.24), MRCY: 17.42 (-0.17), JNPR: 23.84 (+0.19), YHOO: 44.42 (+0.50), T: 34.66 (+0.05), ACE: 113.05 (+0.09), CNMD: 48.98 (+1.80), FTK: 17.49 (+0.78), X: 26.36 (+1.12), AAPL: 127.08 (+0.62), SYK: 94.51 (+1.14), CLMS: 12.96 (-0.08), ETH: 27.00 (-0.24), OTEX: 61.19 (+0.99), AMGN: 153.48 (+0.30), CYT: 52.84 (+0.40), WDC: 107.61 (+0.42), POL: 40.05 (+0.20), TSS: 37.09 (+0.17), EZPW: 9.96 (-0.29), CNI: 70.04 (-0.39), DOX: 51.15 (+0.37), FSL: 37.53 (+2.83)
13.7% Return Seen to Date on SmarTrend Conmed Call (CNMD)
Comtex SmarTrend(R) - Fri Jan 23, 11:23AM CST
SmarTrend identified an Uptrend for Conmed (NASDAQ:CNMD) on October 27th, 2014 at $41.77. In approximately 3 months, Conmed has returned 13.69% as of today's recent price of $47.49.
CNMD: 48.98 (+1.80)
CONMED Announces Preliminary FY14 Results, Guides FY15 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 15, 10:50AM CST
CONMED Corporation (CNMD) estimates full-year 2014 revenues in the range of $739-$741 million while adjusted earnings are projected in the band of $1.90-$1.94 per share.
JNJ: 99.62 (+1.18), MDT: 75.26 (+0.33), CNMD: 48.98 (+1.80), SYK: 94.51 (+1.14)
Conmed reports preliminary results and provides outlook for 2015
Seeking Alpha - at Seeking Alpha - Wed Jan 14, 3:13PM CST
CNMD: 48.98 (+1.80)
CONMED Corporation Announces Preliminary 2014 Results Within Guidance Range and Issues 2015 Financial Guidance
Marketwired - Wed Jan 14, 6:00AM CST
CONMED Corporation (NASDAQ: CNMD) today announced preliminary 2014 results and issued financial guidance for 2015.
CNMD: 48.98 (+1.80)
Powered Surgical Instruments Market by Power Source, Product & by Application - Global Forecasts to 2019
M2 - Thu Jan 08, 6:39AM CST
Research and Markets (http://www.researchandmarkets.com/research/93kr85/powered_surgical) has announced the addition of the "Powered Surgical Instruments Market by Power Source, Product & by Application - Global Forecasts to 2019" report to their offering. The global powered surgical instruments market is estimated to be worth around $1.5 to 1.6 billion in 2014 and is expected to grow at a moderate CAGR during the forecast period of 2014 to 2019. In this report, the global powered surgical instruments market is segmented by power source, product, and application. The market, by power source, is segmented into electric-powered, battery-powered, and pneumatic instruments. By product, the market covers the handpieces; power source and control; and accessories segments. The handpieces market is further subdivided into drills, saws, reamers, staplers, vessel sealing devices, suction coagulators, laparoscopic instruments, shavers, wire/pin drivers, and others. Moreover, the power source and control is divided into electrosurgical units, batteries and chargers, electric consoles, and regulators. The accessories market is subdivided into surgical accessories, electrical accessories, and other accessories. Furthermore, on basis of application, the market is classified into orthopedic surgery, oral maxillofacial surgery, ENT surgery, neurosurgery, plastic and reconstructive surgery, and cardiothoracic surgery. By 2019, North America contributed the largest share to the global powered surgical instruments market, followed by Europe, Asia-Pacific, and RoW. Developed geographies like North America and Europe are likely to grow at a lower CAGR as compared to the Asia-Pacific market, which is expected to show the fastest growth during the forecast period, largely driven by the increased healthcare spending, advancing medical tourism industry, rising prevalence of chronic diseases, and increased accessibility to healthcare facilities. Major players in the powered surgical instruments market are B. Braun Melsungen AG (Germany), CONMED Corporation (U.S.), Covidien Plc (Ireland), Johnson & Johnson (U.S.), Medtronic, Inc. (U.S.), Stryker Corporation (U.S.), and Zimmer Holdings (U.S.), among others. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Global Powered Surgical Instruments Market, By Power Source 8 Global Powered Surgical Instruments Market, By Product 9 Global Powered Surgical Instruments Market, By Application 10 Powered Surgical Instruments Market, By Geography 11 Competitive Landscape 12 Company Profiles - B. Braun Melsungen AG - Brasseler Usa Inc. - Conmed Corporation - Covidien Public Limited Company - Johnson & Johnson - Medtronic, Inc. - Olympus Corporation - Smith and Nephew Plc - Stryker Corporation - Zimmer Holdings, Inc. For more information visit http://www.researchandmarkets.com/research/93...d_surgical
ZMH: 119.33 (+1.18), SNN: 35.82 (-0.28), JNJ: 99.62 (+1.18), MDT: 75.26 (+0.33), CNMD: 48.98 (+1.80), SYK: 94.51 (+1.14)
CONMED Corporation to Announce Fourth Quarter 2014 Financial Results on January 27, 2015
Marketwired - Thu Jan 08, 6:01AM CST
CONMED Corporation (NASDAQ: CNMD) announced today that it will report fourth quarter and full year 2014 financial results at 4:00 PM Eastern time on Tuesday, January 27, 2015, and will also hold a conference call at 4:30 PM Eastern Time that same day to discuss the results.
CNMD: 48.98 (+1.80)
CONMED Corporation to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Marketwired - Thu Dec 11, 6:00AM CST
CONMED Corporation (NASDAQ: CNMD), a medical technology company specializing in medical devices for orthopedic and general surgery, announced today that the Company will participate in the 33rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2015 at 8:30 AM Pacific Time. The event will be held in San Francisco at the Westin St. Francis Hotel.
JPM: 59.67 (+0.10), CNMD: 48.98 (+1.80)
